Skip to main content

A Specific Peptide Vaccine Against IDH1(R132H) Glioma

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. 1.

    Ma W, Jin H, Liu W, Li X, Zhou X, Guo X. Homeobox B8 targets sterile alpha motif domain-containing protein 9 and drives glioma progression. Neurosci Bull 2020, 36: 359–371.

    CAS  Article  Google Scholar 

  2. 2.

    Weller M, Wick W, Aldape K, Brada M, Berger M, Pfister SM, et al. Glioma. Nat Rev Dis Primers 2015, 1: 15017.

    Article  Google Scholar 

  3. 3.

    Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization classification of tumors of the central nervous system: A summary. Acta Neuropathol 2016, 131: 803–820.

    Article  Google Scholar 

  4. 4.

    Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, et al. Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med 2015, 372: 2499–2508.

    CAS  Article  Google Scholar 

  5. 5.

    Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 2010, 465: 966.

    CAS  Article  Google Scholar 

  6. 6.

    Tan AC, Ashley DM, López GY, Malinzak M, Friedman HS, Khasraw M. Management of glioblastoma: State of the art and future directions. CA Cancer J Clin 2020, 70: 299–312.

    Article  Google Scholar 

  7. 7.

    Ransohoff RM, Engelhardt B. The anatomical and cellular basis of immune surveillance in the central nervous system. Nat Rev Immunol 2012, 12: 623–635.

    CAS  Article  Google Scholar 

  8. 8.

    Sampson JH, Gunn MD, Fecci PE, Ashley DM. Brain immunology and immunotherapy in brain tumours. Nat Rev Cancer 2020, 20: 12–25.

    CAS  Article  Google Scholar 

  9. 9.

    Schumacher T, Bunse L, Pusch S, Sahm F, Wiestler B, Quandt J, et al. A vaccine targeting mutant IDH1 induces antitumour immunity. Nature 2014, 512: 324–327.

    CAS  Article  Google Scholar 

  10. 10.

    Peng M, Mo YZ, Wang YA, Wu P, Zhang YJ, Xiong F, et al. Neoantigen vaccine: An emerging tumor immunotherapy. Mol Cancer 2019, 18: 128.

    Article  Google Scholar 

  11. 11.

    Platten M, Bunse L, Wick A, Bunse T, Le Cornet L, Harting I, et al. A vaccine targeting mutant IDH1 in newly diagnosed glioma. Nature 2021, 592: 463–468.

    CAS  Article  Google Scholar 

  12. 12.

    Dang L, Yen K, Attar EC. IDH mutations in cancer and progress toward development of targeted therapeutics. Ann Oncol 2016, 27: 599–608.

    CAS  Article  Google Scholar 

Download references

Acknowledgements

This Research Highlight was supported by the Natural Science Foundation of Zhejiang Province (LR18C090001), the National Natural Science Foundation of China (81801102 and 82071230), and the Research Start-up Project by Hangzhou Normal University (4125C5021920453 and 4125C50220204109).

Author information

Affiliations

Authors

Corresponding author

Correspondence to Zhihui Huang.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Huang, Y., Wang, Y. & Huang, Z. A Specific Peptide Vaccine Against IDH1(R132H) Glioma. Neurosci. Bull. (2021). https://doi.org/10.1007/s12264-021-00791-9

Download citation